Borung’s 'Kanarb' is reaching to the top in 'single ingredient' section
(Yakup Shinmoon)
While there is an intense competition in ARB hypertension treatment market, domestic new drug 'Kanarb' from Boryung is reaching to the top in 'single ingredient' section.
According to the data from UB Care, in ARB single ingredient market (local hospitals and general hosp...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
